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Abstract
Background: There is little information on the application and impact of revised criteria for diagnosing dementia
and mild cognitive impairment (MCI), now termed major and mild neurocognitive disorders (NCDs) in the DSM-5.
We evaluate a psychometric algorithm for diagnosing DSM-5 NCDs in a community-dwelling sample, and characterize
the neuropsychological and functional profile of expert-diagnosed DSM-5 NCDs relative to DSM-IV dementia and
International Working Group criteria for MCI.
Methods: A population-based sample of 1644 adults aged 72–78 years was assessed. Algorithmic diagnostic criteria
used detailed neuropsychological data, medical history, longitudinal cognitive performance, and informant interview.
Those meeting all criteria for at least one diagnosis had data reviewed by a neurologist (expert diagnosis)
who achieved consensus with a psychiatrist for complex cases.
Results: The algorithm accurately classified DSM-5 major NCD (area under the curve (AUC) = 0.95, 95% confidence
interval (CI) 0.92–0.97), DSM-IV dementia (AUC = 0.91, 95% CI 0.85–0.97), DSM-5 mild NCD (AUC = 0.75, 95% CI 0.70–0.
80), and MCI (AUC = 0.76, 95% CI 0.72–0.81) when compared to expert diagnosis. Expert diagnosis of dementia using
DSM-5 criteria overlapped with 90% of DSM-IV dementia cases, but resulted in a 127% increase in diagnosis relative to
DSM-IV. Additional cases had less severe memory, language impairment, and instrumental activities of daily living
(IADL) impairments compared to cases meeting DSM-IV criteria for dementia. DSM-5 mild NCD overlapped with 83%
of MCI cases and resulted in a 19% increase in diagnosis. These additional cases had a subtly different neurocognitive
profile to MCI cases, including poorer social cognition.
Conclusion: DSM-5 NCD criteria can be operationalized in a psychometric algorithm in a population setting. Expert
diagnosis using DSM-5 NCD criteria captured most cases with DSM-IV dementia and MCI in our sample, but included
many additional cases suggesting that DSM-5 criteria are broader in their categorization.
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Background
Revised criteria for diagnosing dementia and mild cogni-
tive impairment (MCI), now termed major and mild
neurocognitive disorders (NCDs), respectively, in the
Diagnostic and Statistical Manual of Mental Disorders,
Fifth Edition (DSM-5) [1], has the potential to signifi-
cantly impact on clinical and research settings. Recent
reviews [2, 3] note the increased clarity and structure in
DSM-5 NCD for assessing cognitive impairment, de-
cline, and functional impact when compared to DSM-IV
dementia or International Working Group (IWG) cri-
teria for MCI [4]. The clearer criteria and greater em-
phasis on objective measures mean that the DSM-5
NCD categories should be easier to operationalize in
large-scale studies of ageing using a psychometric algo-
rithm. Algorithmic approaches to diagnosing NCDs are
particularly valuable in resource-intensive population
studies [5] and in settings where there is limited access
to biomarkers and clinical services. Globally, most de-
mentia cases occur in such settings [6]. Algorithmic ap-
proaches to DSM-IV and DSM-III-R dementia diagnosis
have been previously published with agreement ranging
from κ (Cohen’s kappa) = 0.63 to 0.84 [5, 7, 8]. No study
has as yet examined the algorithmic diagnosis of DSM-5
NCD. The present study fills this gap.
Given that both major and mild categories of NCD are
designed to be age- and etiology-independent syndromes,
it is expected that, when applied to older adults, the
prevalence estimates would be higher than for the more
‘Alzheimer’s-centric’ DSM-IV dementia category [2, 9],
whereas MCI criteria [4, 10] are much broader and are
not age- or Alzheimer’s disease (AD)-specific. Field trials
of DSM-5 suggested a similar prevalence of DSM-IV de-
mentia and DSM-5 major NCD [11]. However, a number
of recent studies [12–14] report differences between the
DSM-5 and existing diagnostic systems, with one report-
ing increased prevalence of diagnosis with DSM-5 criteria
relative to DSM-IV and MCI [14], and others reporting
decreased diagnosis relative to systems such as 10/66
criteria [12], Petersen MCI criteria [13], and IWG-MCI
criteria [14, 15]. The variance in findings may reflect dif-
ferences in the diagnostic systems used for comparison,
sensitivity of different cognitive batteries, as well as the
samples studied (e.g., memory clinic [14], population-
based cohort [12, 13, 15], middle-income nations [12, 14]).
In the context of these mixed findings, it is important to
better understand the implications of applying DSM-5
NCD criteria to existing epidemiological studies with well
characterized samples that have been followed longitudin-
ally with neurocognitive diagnoses.
The aims of the present study were twofold. The first
aim was methodological and sought to develop and
evaluate a psychometric algorithm to assess participant
data against criteria for the following diagnoses: DSM-5
major NCD, DSM-5 mild NCD, DSM-IV dementia, and
IWG MCI. Algorithmic classification was compared to
diagnosis of the same categories by experienced clinicians
(expert diagnosis). The second aim was to examine the
overlap between expertly diagnosed DSM-5 NCDs, DSM-
IV dementia, and MCI, and characterize the groups in
terms of their neuropsychological and functional profiles.
Methods
Participants
The participants were from the Personality and Total
Health Through Life Project (PATH) which has been previ-
ously described [16]. Briefly, we recruited participants who
were residents of the city of Canberra and adjacent town of
Queanbeyan, Australia. Participants aged within three nar-
row cohorts (20–24, 40–44, and 60–64 years) were sampled
randomly from the electoral roll and invited to participate
in a study on the risk and protective factors for common
mental disorders. Enrolment to vote is compulsory for
all Australian citizens. The study protocol was ap-
proved by the Australian National University’s Human
Research Ethics Committee (Protocols: 2009/039; 2009/
308; 2012/074; 2006/0314; 2002/0189) and participants
provided written informed consent after receiving a
complete description of the study. A total of 7485 con-
sented to participate. The present study focuses on the
older age cohort whose sample size at wave 1 (data col-
lection 2001–2002) was 2551 (58.3% of the cohort’s
random sample). Participants were re-assessed every
4 years on a broad range of sociodemographic, health,
lifestyle, and neuropsychological measures. Sample re-
tention has been high at each wave (between 85.4% and
88.8%). This study reports data from the 12-year
follow-up of the older cohort who were aged 72–78 at
wave 4 (data collection 2014–2015).
Interview and assessment
Of the 2048 participants contacted for follow-up at wave
4, 116 were deceased, 259 refused, and 14 were not found
(Fig. 1). Data were obtained from individual face-to-face
or telephone interviews conducted with 1644 participants
by trained research personnel, including demographic,
general health, anthropometric, physiological, and neuro-
cognitive measures.
Demographics, depression and general health survey
An interviewer-administered survey collected data on the
level of education, psychological measures, substance and
medication use, psychiatric and medical history, including
recent major surgery, activities of daily living, housing,
home or personal care, and non-English speaking back-
ground. Depressive symptoms were screened using the
self-report screen for DSM-IV criteria for depression, the
Patient Health Questionnaire (PHQ-9) [17].
Eramudugolla et al. Alzheimer's Research & Therapy  (2017) 9:15 Page 2 of 12
Cognitive assessment
A battery of neurocognitive measures was developed to
address each of the domains described in the DSM-5 [1]
(see Additional file 1: Table S1), and administered by
trained research interviewers. Measures were selected on
the basis of sensitivity to dementia and age-related cog-
nitive impairment as well as efficiency of administration
and scoring. Data on behavioral changes were obtained
through the informant interview (see later). Briefly, the
following measures were used to assess each of the do-
mains: complex attention (Symbol Digits Modalities Test
[18], Trail Making Test A [19], Reaction Time Test
[20]); executive function (Digit Span Backwards [21],
Trail Making Test B (19), Stroop Color Word Test [22],
Zoo Map Test [23], Game of Dice Test [24]); learning and
memory (California Verbal Learning Test [25], Benton
Visual Retention Test (Administration B) [26]); language
(Letter Fluency [19], Boston Naming Test-15 item [27],
Spot The Word Test [28]); perceptual motor (Purdue
Pegboard [29], Ideomotor Apraxia Test (IAT) [30], Benton
Visual Retention Test (Administration C) [26]); social cog-
nition (Reading the Mind in the Eyes [31]). Details on test
measures are provided in a supplementary methods sec-
tion (see Additional file 1). Scores were converted to z
Fig. 1 Flow of participants through the PATH study and through wave 4. Diagnosis refers to DSM-5 neurocognitive disorders, IWG MCI,
and DSM-IV dementia
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scores by normalizing relative to the whole wave 4 PATH
sample data stratified by gender and education (low: 5–10
years, medium: 10–15 years; high: 15+ years).
Screen 1
The data for the 1644 participants assessed at wave 4
were screened for signs of decline based on the criteria
detailed in Additional file 1. Briefly, this included either
a previous PATH diagnosis of dementia or a mild cogni-
tive disorder, or evidence of current objective cognitive
impairment (based on performance ≤6.7th percentile on
at least one cognitive measure, or Mini-Mental Status
Examination (MMSE) ≤24), and evidence of subjective
decline on the Memory and Cognition Questionnaire
(MAC-Q) [32] or decline on the MMSE of >3 points
since wave 3, or consistent MMSE ≤24 at waves 3 and 4.
Of the participants meeting criteria for any of the above
(n = 623), the majority (n = 426) had a detailed informant
interview. Of the remaining 1021 participants not meet-
ing the criteria, most (n = 746) received a basic inform-
ant interview (Fig. 1).
Informant interview
Participants (n = 1438) consented to have an informant
(spouse, friend, neighbor or relative) interviewed by tele-
phone regarding the participant’s changes in cognition
and activities of daily life. The basic informant interview
comprised the Bayer instrumental activities of daily liv-
ing (IADL) questionnaire [33] and the Informant Ques-
tionnaire of Cognitive Decline in the Elderly 16-item
Short Version (IQCODE) [34]. The detailed informant
interview comprised the Bayer IADL, IQCODE, Dysexe-
cutive Questionnaire (DEX-Q) [23], and Neuropsychi-
atric Inventory (NPI) [35], as well as questions on
medical history (Parkinson’s disease, Alzheimer’s disease,
other dementia, stroke, psychiatric diagnoses, memory
complaints), recent behavior including symptoms of de-
lirium, psychosis, hallucinations, alertness and physical
function, sensory or motor loss, and onset and progres-
sion of cognitive difficulties. The DEX-Q [23] collected
data on executive difficulties affecting social and daily
activity. The NPI [35] collected data on non-cognitive
symptoms of MCI and dementia.
Psychometric algorithm
Those identified by screen 1 (n = 623) had all interview
and informant data entered into a case file spreadsheet.
To minimize effects of non-response bias, case files with
missing informant data (n = 59) were also screened by
the algorithm. The algorithm combined the neurocogni-
tive assessment data with the informant and survey data
on medical history to operationalize criteria (criterion
met/not met) for each diagnostic category: DSM-5 major
NCD, mild NCD, DSM-IV dementia, and MCI (see
Tables 1 and 2). Details of the neuropsychological bat-
tery are provided in Additional file 1. Cognitive scores
were standardized relative to the gender- and education-
stratified norms (from the whole PATH 60s sample at
wave 4) and converted to z scores. Severe cognitive im-
pairment was defined as a z score < –2.0. Given a lack of
consensus in the literature regarding appropriate cut-
offs for defining mild cognitive impairment, separate al-
gorithmic categories were created using z score > –2.0
and ≤ –1.0, and > –2.0 and ≤ –1.5. In addition to the
diagnostic categories of interest to the current study, the
algorithm also classified participants according to other
categories (e.g., age-associated memory impairment [36],
age-associated cognitive decline [37], DSM-IV mild
NCD, etc.). Participants not meeting criteria for any
diagnostic category were classified as “normal”. Those
meeting criteria for at least one diagnosis (n = 368) had
their data reviewed by the research neurologist (Fig. 1).
Expert diagnosis and consensus
Case files (n = 368) were reviewed by an experienced re-
search neurologist (CM); these included neuropsycho-
logical test data, informant data, structural brain magnetic
resonance imaging (MRI) scans to aid differential diagno-
sis of dementia subtypes (n = 54), a self-reported medica-
tion list, and contact details of the participant for further
clarification of details relevant to diagnosis (n = 21). The
neurologist based her decisions on all available data,
guided by the DSM-5 NCD, DSM-IV, and MCI diagnostic
criteria, and used clinical judgement to determine whether
each criterion was supported by the data. Inter-rater reli-
ability with an experienced psychiatrist (RK) independ-
ently reviewing a subsample of 29 cases indicated high
agreement for dementia (DSM-IV and DSM5 major NCD:
κ = 0.79, 95% confidence interval (CI) 0.54–1.0, p < 0.01),
and moderate agreement for mild cognitive disorders
(MCI and DSM5 mild NCD: κ = 0.47, 95% CI 0.13–0.73,
p < 0.01) which are within the ranges reported in field
trials [7, 11, 38].
Further to estimating inter-rater reliability, consensus
diagnosis was conducted by the two physicians and a
neuropsychologist (RE) on complex cases identified as
meeting at least one of the following criteria: (1) comor-
bid depression (moderate to severe on PHQ-9); (2) other
comorbid psychiatric conditions; (3) stroke; (4) dementia
or DSM-5 major NCD without memory impairment. A
total of n = 60 met the above criteria and diagnoses were
reviewed for consensus.
Statistical analysis
To evaluate the accuracy of algorithmic classification
relative to the expert diagnoses, we used the binary algo-
rithmic criteria (equally weighted) as predictors of expert
diagnosis in logistic regression models, saving the model
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predicted probabilities. We then conducted receiver op-
erating characteristic (ROC) analyses of each probability
variable against the corresponding binary diagnosis vari-
able. Cross-tabulation and kappa (κ) statistics were used
to evaluate agreement between algorithmic and expert
diagnosis, with bootstrapping of 1000 samples to esti-
mate 95% CIs on the kappa. Overlap between the differ-
ent diagnostic criteria when used by clinicians was
examined using crosstabs. Generalized linear models
(GLM) were used to examine mean differences in each




Compared to those selected as ‘normal’ at screen 1 (n =
1021) and the algorithmic screen (n = 255), the sample se-
lected for expert review (n = 368) had significantly lower
MMSE scores (27.4 (standard deviation (SD) = 2.7) vs 29.2
(SD = 0.95), p < 0.001), greater depressive symptomatology
on PHQ-9 (3.8 (SD = 3.9) vs 2.7 (SD = 3.1), p < 0.001),
higher frequency of males (56.8% vs 50.5%, p < 0.05), and
similar frequency of carrying at least one APOE e4 allele
(31% vs 26%, p = 0.052). There were no differences in age
(75.2 years (SD = 1.6) vs 75.1 (SD = 1.5), p > 0.10) or de-
mentia family history (23% vs 22%, p > 0.10).
Accuracy of psychometric algorithm for DSM-5 NCDs,
DSM-IV dementia, and MCI
The algorithm classified 72 cases as meeting criteria for
DSM-5 major NCD. ROC analysis of logistic regression-
derived algorithmic probability of diagnosis against expert
diagnosis indicated excellent accuracy (area under the
curve (AUC) = 0.95, 95% CI 0.92–0.97) (Fig. 2a). Of these
72 cases, 54 (75%) were confirmed by the clinicians,
representing an overall high level of agreement (κ = 0.72,
95% CI 0.62–0.80).
Twenty-seven cases were diagnosed as DSM-IV de-
mentia by the algorithm. ROC analysis indicated excel-
lent accuracy relative to expert-diagnosed DSM-IV
dementia (AUC = 0.91, 95% CI 0.85–0.97) (Fig. 2a). Of
the 27 cases, 19 (70.4%) were expert-confirmed, yielding
a high level of agreement (κ = 0.64, 95% CI 0.47–0.78).
When a cut-off of 1 SD was applied to identify cognitive
impairment in the mild range, the algorithm classified 220
cases as DSM-5 mild NCD, of which 141 (64.1%) were
expert-confirmed (κ = 0.43, 95% CI 0.33–0.52). ROC ana-
lysis revealed very good prediction of expert diagnosis
(AUC= 0.75, 95% CI 0.70–0.80) (Fig. 2). When a cut-off of
1.5 SD was applied, 143 cases were classified as DSM-5
mild NCD, of which 96 (67.1%) were expert-confirmed
(κ =0.34, 95% CI 0.22–0.43). ROC analysis showed good
prediction of expert diagnosis (AUC = 0.76, 95% CI
0.71–0.81) (Fig. 2b).
For MCI, algorithmic diagnosis using a cut-off of 1 SD
resulted in 190 cases being classified with 113 (59.5%)
confirmed by expert diagnosis (κ =0.42, 95% CI 0.33–
0.51). ROC analysis indicated very good accuracy (AUC
= 0.76, 95% CI 0.72–0.81) (Fig. 2b). When a cut-off of
1.5 SD was applied, 124 cases were identified, with 76
(61.3%) being expert confirmed (κ = 0.32, 95% CI 0.22–
0.41), with ROC indicating very good prediction (AUC =
0.77, 95% CI 0.72–0.82) (Fig. 2b).
Predictive value of individual algorithmic criteria for
identifying algorithm and expert diagnosis
Positive (PPV) and negative predictive values (NPV) of
individual criteria (see Additional file 1: Table S2) are
presented as functions of source of diagnosis (i.e., algo-
rithm or expert). Predictive values were obtained using
Fig. 2 Receiver operating curve (ROC) for discriminating clinically diagnosed categories from algorithm-based categories (n = 368). a Dementia and
major neurocognitive disorder (ND). b International Working Group mild cognitive impairment (IWG MCI) and mild ND with comparison between
cognitive cut-offs (1.5 SD and 1.0 SD). AUC area under the curve, CI confidence interval, DSM Diagnostic and Statistical Manual of Mental Disorders
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crosstabs of observed frequencies of those meeting each
criterion against those achieving diagnosis. In general,
the pattern of PPV for individual criteria was similar for
algorithmic and expert diagnosis.
Sensitivity analysis
Informant data was unavailable for 59 (9.5%) of the cases
selected by screen 1 (Fig. 1). Within this group, the dis-
tribution of dementia/major NCD (n = 3 (5.1%)) or
MCI/mild NCD (n = 12 (20.3%)) was similar to that in
the full sample (n = 71 (4.3%) and n = 196 (11.9%), re-
spectively) (χ2(2) = 3.96, p = 0.14). To examine the im-
pact of missing data on the analyses of algorithm
accuracy, cross-tabulation and κ statistics were obtained
for only those that had informant data (n = 346). Agree-
ment was similar to that found in the full sample: major
NCD κ = 0.73, 95% CI 0.63–0.82; mild NCD κ = 0.43,
95% CI 0.33–0.51; dementia κ = 0.63, 95% CI 0.44–0.78;
and MCI κ = 0.43, 95% CI 0.34–0.53.
Overlap between expert diagnosed DSM-5 NCDs and
DSM-IV dementia and MCI
Cross-tabulation of expert-diagnosed DSM-5 major NCD
against DSM-IV dementia showed a moderate level of
overlap (κ =0.49, standard error (SE) = 0.06, p < 0.001)
(Table 3). Of the 30 cases meeting criteria for DSM-IV de-
mentia, 27 (90%) also met criteria for DSM-5 major NCD.
The three cases meeting DSM-IV dementia but not DSM-
5 major NCD both received AD etiological specifiers and
met criteria for DSM-5 mild NCD. The DSM-5 identified
41 additional cases as dementia, representing a 127% in-
crease in dementia diagnosis in the sample relative to
DSM-IV, and a high positive predictive value (PPV = 0.88;
NPV = 0.90). These additional cases included a few with
vascular, fronto-temporal, and Parkinson’s specifiers. They
also had a higher rate of previous diagnoses (36.6%) rela-
tive to cases without any expert-diagnosed dementia
(3.4%) (p < 0.001), and a similar rate to those meeting cri-
teria for both DSM-5 and DSM-IV dementia diagnoses
(40%) (p > 0.05). Cases qualifying for both DSM-5 major
NCD and DSM-IV dementia were also more likely to
carry at least one APOE e4 allele (55.2%) compared to
those meeting only the DSM-5 major NCD diagnosis
(14.6%) (p < 0.001), with the latter being statistically not
different from the APOE e4 allele frequency in cognitively
normal participants (25.8%) (p > 0.05).
There was a moderate level of overlap (κ = 0.58, SE =
0.04) between DSM-5 mild NCD and MCI diagnosis. Of
the 144 cases qualifying for MCI, 119 (82.6%) were also
given DSM-5 mild NCD diagnosis. The 25 MCI cases
missed by DSM-5 mild NCD did not qualify for a diag-
nosis of DSM-5 major NCD or any other diagnostic cat-
egory. They were mostly of the amnestic multi-domain
(n = 9) and non-amnestic single domain (n = 9) subtypes.
An additional 52 cases also received mild NCD diagnosis,
representing an overall 19% increase in mild cognitive dis-
order diagnoses in our sample (PPV = 0.78; NPV = 0.82).
Characterization of neuropsychological profiles as a
function of expert diagnosis overlap
A series of GLMs compared neurocognitive profile as a
function of diagnosis. GLM analysis revealed that cases di-
agnosed with only DSM-5 major NCD had significantly
better language (p < 0.01), memory encoding (p < 0.001),
and IADL function (p < 0.05) compared to cases that also
met DSM-IV dementia criteria (Fig. 3a).
Figure 3b presents neuropsychological profiles as a
function of DSM-5 mild NCD and MCI. Relative to
Table 3 Overlap between expert diagnoses using DSM-5 criteria and DSM-IV for dementia and MCI
DSM-IV dementia DSM-5 major NCD MCI DSM-5 mild NCD
No Yes No Yes
No 297 (87.9%) 41 (12.1%) No 172 (76.8%) 52 (23.2%)
Yes 3 (10.0%) 27 (90.0%) Yes 25 (17.4%) 119 (82.6%)
Kappa 0.494 (0.063) p < 0.001 Kappa 0.575 (0.043) p < 0.001
Specifiers DSM-5 DSM-IV Specifiers/subtypes DSM-5 MCI
Probable Alzheimer’s 17 (25%) 18 (60%) Amnestic—single 42 (24.6%) 46 (31.9%)
Possible Alzheimer’s 8 (11.8%) 7 (23.3%) Amnestic—multiple 40 (23.4%) 49 (34.0%)
Probable vascular 3 (4.4%) 1 (3.3%) Non-amnestic—single 27 (15.8%) 36 (25%)
Possible vascular 4 (5.9%) 0 (0%) Non-amnestic—multiple 9 (5.3%) 12 (8.3%)
Parkinson’s 4 (5.9%) 3 (10%) Probable Alzheimer’s 2 (1.2%) 0 (0%)
Lewy body 1 (1.5%) 1 (3.3%) Possible Alzheimer’s 2 (1.2%) 0 (0%)
Fronto-temporal 3 (4.4%) 0 (0%)
Unspecified 28 (41.2%) 0 (0%) Unspecified 49 (34.4%) –
Total 68 30 Total 171 144
DSM Diagnostic and Statistical Manual of Mental Disorders, MCI mild cognitive impairment, NCD neurocognitive disorder
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normal controls, cases with either DSM-5 mild NCD,
MCI, or both performed poorly in all domains except
IADLs. Relative to cases with only MCI, cases given only
DSM-5 mild NCD diagnoses had poorer memory encod-
ing (p < 0.05) and poorer social cognition (p < 0.05), but
better planning and decision making (p < 0.05).
Discussion
Algorithm accuracy
We report the first algorithmic approach to classifying
DSM-5 NCDs. The algorithm used had good accuracy
when classifying major NCD (κ = 0.72, AUC = 0.95) and
DSM-IV dementia (κ = 0.64, AUC = 0.91) and was rea-
sonably accurate when classifying MCI (κ = 0.42, AUC =
0.75) and mild NCD (κ = 0.43, AUC = 0.76). The findings
indicate that a psychometric algorithm is capable of pre-
dicting clinical diagnosis in a population-based sample
of older adults, and is consistent with previous work
suggesting better algorithmic prediction of more severe
diagnoses compared to milder diagnoses [5, 7]. Our find-
ings also support field trials of the DSM-5 NCD [11]
which found that the reliability of mild NCD was
Fig. 3 Cognitive profiles as a function of diagnostic category. a Mean z score (standardized relative to education- and gender-stratified norms
for the whole PATH sample) for tests in each cognitive domain as a function of diagnostic category: DSM-IV dementia (n = 30), DSM-5
major NCD only (n = 41), no diagnosis (n = 1380). b Mean z score for cognitive domain as a function of diagnosis: MCI only (n = 25), DSM-5 mild NCD
only (n = 52), both MCI and DSM-5 mild NCD (n = 119). Error bars represent 1 standard error (SD). Cognitive Control Trails B and Digits Backward;
Response Inhibition Stroop, Go NoGo test; Planning and Decision Making Zoo Map sequencing and error, Dice test safe choices and strategy
changes; Memory Encoding California Verbal Learning Test Delayed Recall, Recognition Hits and Misses; Memory Retrieval California Verbal Learning Test
Trial 1, Trial 3 and Delayed Recall. DSM Diagnostic and Statistical Manual of Mental Disorders, IADLs instrumental activities of daily living, MCI mild
cognitive impairment, NCD neurocognitive disorder
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generally lower and less consistent than that of major
NCD, which was very good. The algorithm for DSM-5
criteria produced slightly more accurate prediction of
expert diagnosis compared to DSM-IV dementia criteria
or IWG MCI criteria, supporting our hypothesis that the
clearer, more structured DSM-5 criteria may be easier to
operationalize. Agreement between algorithmic and ex-
pert diagnosis ranged between κ = 0.42 and κ = 0.72,
consistent with previously published algorithms [5, 7, 8].
We also found that the cognitive cut-off used to define
mild impairment (either 1.0 or 1.5 SD) had minimal im-
pact on the rate of diagnosis of either DSM-5 mild NCD
or IWG MCI diagnosis.
The individual diagnostic criteria that were predictive
of expert-diagnosed major NCD and DSM-IV dementia
were similarly predictive of algorithm-defined major
NCD and dementia, with cognitive impairment and
IADL impact having the highest PPV. Individual criteria
were less predictive for the mild diagnoses, but those
with highest PPVs included cognitive impairment, sub-
jective concern, and exclusion of dementia (in the case
of MCI). The lower predictive value of algorithmic cri-
teria for delirium and other disorders for expert diagno-
ses suggest greater reliance on clinical judgement when
determining their likely impact.
DSM-5 overlap with DSM-IV and MCI, and comparison of
neurocognitive profiles
We also found that expert diagnosis of dementia accord-
ing to DSM-5 had excellent overlap with DSM-IV (90%);
however, a large number of additional cases were identi-
fied by DSM-5 resulting in a 127% increase in diagnosis.
This confirms the findings of Tay et al. [14] in a memory
clinic sample (n = 234) where they found that DSM-5
major NCD criteria captured all cases of DSM-IV demen-
tia, but with an additional 39.7% cases. These additional
cases, however, had a similar rate of previous diagnoses
(either MCI or dementia) to cases meeting only DSM-IV
dementia, and a significantly higher rate than those with-
out dementia, suggesting the more inclusive criteria cap-
tured additional cases with similarly chronic deficits.
Aside from the different populations, our higher rate
of additional diagnosis may reflect our use of more de-
tailed neurocognitive measurement, detailed informant
report, and inclusion of etiological specifiers and struc-
tural MRI evidence. In the absence of sufficient data on
the degree of impairment or biological evidence of
change, cases not meeting DSM-IV dementia are more
likely to be labeled as mild. While Tay et al. [14] labeled
as MCI most of those who were DSM-5 major NCD but
not DSM-IV dementia, none of our additional DSM-5
major NCD cases met criteria for MCI. Instead, they
were more likely to receive a vascular specifier, fronto-
temporal or Parkinson’s dementia. Although memory
impairment was less severe for the group with only
DSM-5 major NCD, the relative severity of impairment
in other cognitive domains, as well as reported impact
on IADLs, show that this group should be considered as
dementia. Thus, our findings suggest that additional de-
mentia cases identified by DSM-5 are not necessarily at a
milder stage but present with a different neuropsycho-
logical profile, and possibly different etiologies, compared
to cases meeting dementia criteria for both DSM-5 and
DSM-IV where the pattern of impairment and APOE e4
allele distribution is more supportive of AD. Future
research including additional biomarkers will enable
evaluation of this finding.
Although the mild NCD criteria were not developed
as an explicit replacement for IWG MCI, in the context
of ageing-associated progressive NCDs, clinicians may
consider them as an alternative. Accordingly, diagnosis
of DSM-5 mild NCD was highly sensitive to MCI (83%)
and showed a moderate agreement with MCI diagnosis
(κ = 0.58), albeit with an overall 19% increase in the rate
of diagnosis. This contrasts with Tay et al. [14] who re-
ported a decrease of 54% using DSM-5 mild NCD criteria,
and attributed this to difficulties defining the level of
IADL impairment appropriate for mild NCD. Population-
based samples are more likely to contain individuals with
very little functional impairment but sufficient cognitive
deficits and decline to warrant a mild NCD diagnosis.
Luck et al. [15] reported a much higher agreement be-
tween MCI and DSM-5 mild NCD, but assessed each
neurocognitive domain with a single test. Our use of a
range of tests and obtaining average performance across
the domain is likely more sensitive to true impairment
but more variable. In fact, in our sample, 17.4% of MCI
cases failed to be captured by DSM-5, and there were
differences in neuropsychological profile, such that cases
meeting only DSM-5 mild criteria had poorer social cog-
nition and memory, supporting previous findings [15],
but better performance on planning and decision-
making. This suggests the inclusion of a greater range of
neurocognitive domains in DSM-5, and particularly the
inclusion of social cognition as a criterion, may help cap-
ture impaired individuals not detected by MCI criteria.
Follow-up studies are required to examine the progres-
sion and predictive value of these cases.
Our study is limited by expert diagnosis based on case
file review rather than clinical interview; however, this
meant that our clinical diagnoses were based on the
same data as those operationalized in the algorithm.
Nevertheless, further work is required to validate these
findings in independent data sets. Strengths include the
large, population-based sample, detailed neurocognitive
assessment, comparison of different cognitive cut-offs,
and a systematic approach to collecting and analyzing
evidence for impairment. The findings suggest that
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clinicians, trialists, and epidemiologists using the DSM-5
criteria should expect higher estimates of disease preva-
lence and incidence, and the ability to capture a broader
range of etiologies and severities compared to DSM-IV
and MCI. The findings also suggest that while MCI and
mild NCD do overlap, MCI is not fully captured within
the mild NCD construct. A similar pattern may be ap-
parent for the forthcoming ICD-11 criteria if it adopts
an approach analogous to DSM-5 [39].
Conclusions
In summary, an algorithm-based approach to DSM-5
diagnosis of NCD is feasible in cohort studies. This ap-
proach is more accurate at identifying major NCD than
mild NCD. DSM-5 is more inclusive of the variety of clin-
ical profiles of major NCD, resulting in higher rates of
diagnosis but with good negative predictive power. The
findings have implications for understanding the impact
on rates of diagnosis when using the revised diagnoses.
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